SEC FORM 3

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

McGill Iain

(Last)

(First)

(Middle)

C/O JAZZ PHARMACEUTICALS PLC

CONNAUGHT HOUSE, 1 BURLINGTON RD, FL. 4

(Street)

DUBLIN 4

(City)

(State)

(Zip)

2. Date of Event Requiring Statement (Month/Day/Year)
07/31/2014

3. Issuer Name and Ticker or Trading Symbol
Jazz Pharmaceuticals plc [ JAZZ ]

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director	10% Owner
X	Officer (give title below)	Other (specify below)
	Head of EUSA Int'l & SVP

5. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)
Ordinary Shares	27,553⁽¹⁾	D

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
1. Title of Derivative Security (Instr. 4)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
Nonstatutory Stock Option (right to buy)	⁽²⁾	08/08/2022	Ordinary Shares	22,500	$46.83	D
Nonstatutory Stock Option (right to buy)	⁽³⁾	03/04/2023	Ordinary Shares	8,500	$59.13	D
Nonstatutory Stock Option (right to buy)	⁽⁴⁾	02/26/2024	Ordinary Shares	11,500	$166.62	D

Explanation of Responses:

1. Including 25,250 restricted stock units ("RSUs") granted pursuant to the Issuer's 2011 Equity Incentive Plan. Each RSU represents a contingent right to receive one ordinary share upon the vesting of the unit. Of the 25,250 RSUs, 15,000 RSUs vest in three equal annual installments from August 9, 2014 to August 9, 2016, 4,500 RSUs vest in three equal annual installments from March 5, 2015 to March 5, 2017, and 5,750 RSUs vest in four equall annual installments from February 27, 2015 to February 27, 2018.

2. This option was granted pursuant to the Issuer's 2011 Equity Incentive Plan. The ordinary shares subject to this option vested with respect to 1,666 shares and vest with respect to 20,834 shares in equal monthly installments from August 9, 2014 to August 9, 2016.

3. This option was granted pursuant to the Issuer's 2011 Equity Incentive Plan. The ordinary shares subject to this option vested with respect to 750 shares and vest with respect to 7,750 shares in equal monthly installments from September 5, 2014 to March 5, 2017.

4. This option was granted pursuant to the Issuer's 2011 Equity Incentive Plan. 1/4th of the ordinary shares subject to this option vest on February 27, 2015 and the remainder vest in equal monthly installments from March 27, 2015 to February 27, 2018.

Remarks:

	/s/ Larissa Schwartz as attorney in fact for Iain McGill	08/07/2014
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.